Location: Home
  • search
  • go
  • Relate News
  • 8/9/2018Pfizer's Breast Cancer Drug Ibrance Receives Approval in China
  • 8/9/2018BeiGene Drops 5% on Hong Kong IPO Debut
  • 8/9/2018EdiGene Raises $15M Pre-Series B Led by Lilly Asia Ventures
  • 8/9/2018Harbour BioMed and Glenmark Pharma Sign Agreement for Greater China to...
  • 8/8/2018CDE Solicits Comments on List of Urgently-needed New Drugs Marketed Ov...
  • 8/8/2018CBT Pharma Gets Ethics Approval for APOLLO-1 Phase 1/2 Trial for Hepat...
  • 8/8/2018IQVIA: Overview of the Chinese Pharmaceutical Market in 2017
  • 8/8/2018Novartis Voluntarily Withdraws Zemeta for Injection in China, Followin...
  • 8/8/2018Novartis China Reorganizes to Better Position for New Business
  • 8/7/2018CNDA Approves Gilead's HIV Drug Genvoya
  • 8/7/2018MorphoSys and I-Mab Announce China IND Submission of mAb for MM
  • 8/7/2018Two More Chinese Pharma Groups Recall Tainted Blood-Pressure Drug
  • 8/7/2018Synergy Out-licenses China Rights of Constipation Drug to Luoxin Pharm...
  • 8/7/2018NHC Investigating A New Vaccine Case Involving Expired Vaccines in Sha...
  • 8/7/2018State Council Issues New Guideline to Enhance Medical Sector Regulatio...
  • 8/7/2018Can-Fite and with CMS Medical Sign License Agreement for Piclidenoson ...
  • 8/6/2018China Braces for More Pain from Trade War as Economy Slows
  • 8/6/2018China-related Drug Scandals Showcase Risks in Global Supply Chains
  • 8/6/2018Harbour BioMed and Glenmark Pharma Sign Anticancer License Agreement f...
  • 8/3/2018NHC Drafts Document to Improve the National Essential Drug System
  • 8/3/2018Recent Executive Moves
  • 8/3/2018China Ups Pressure on MNCs in the Wake of Intriguing Film about Smuggl...
  • 8/3/2018China Isn't Yet Ready to Conduct Clinical Trials for The Pharma Indust...
  • 8/3/2018Nobel Laureate to Launch Biomedicine Laboratory in Shenzhen
  • 8/3/2018Acticor Licenses Stroke Medicine to CMS in China and Select Asian Mark...
  • 8/2/2018AstraZeneca CEO Gambles on China's Internet of Things
  • 8/2/2018Laekna Inks Deal with Novartis for Global Rights of Two Anticancers
  • 8/2/2018Solasia Pharma Receives Chinese Approval of Transdermal Nausea Drug
  • 8/2/2018Eisai Licenses Anti-Obesity Drug Lorcaserin in China to CY Biotech
  • 8/2/2018Clover Biopharma Initiates Phase I Study of Etanercept Biosimilar in C...
  • Page:329/789 Total number of articles:23668: [First][<<] [327] [328] [329] [330] [331] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group